Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trial
Resource Type
Article
Authors
Mirza, Mansoor Raza ; Åvall Lundqvist, Elisabeth ; Birrer, Michael J ; dePont Christensen, Rene ; Nyvang, Gitte-Bettina ; Malander, Susanne ; Anttila, Maarit ; Werner, Theresa L ; Lund, Bente ; Lindahl, Gabriel ; Hietanen, Sakari ; Peen, Ulla ; Dimoula, Maria ; Roed, Henrik ; Ør Knudsen, Anja ; Staff, Synnöve ; Krog Vistisen, Anders ; Bjørge, Line ; Mäenpää, Johanna U
Source
In The Lancet Oncology October 2019 20(10):1409-1419
Subject
Primary Research Articles
Language
ISSN
1470-2045